ATE191791T1 - Verfahren für die bestimmung von antikörpern in seronegativen personen - Google Patents

Verfahren für die bestimmung von antikörpern in seronegativen personen

Info

Publication number
ATE191791T1
ATE191791T1 AT93900599T AT93900599T ATE191791T1 AT E191791 T1 ATE191791 T1 AT E191791T1 AT 93900599 T AT93900599 T AT 93900599T AT 93900599 T AT93900599 T AT 93900599T AT E191791 T1 ATE191791 T1 AT E191791T1
Authority
AT
Austria
Prior art keywords
hiv
individuals
whole blood
seronegative
blood
Prior art date
Application number
AT93900599T
Other languages
English (en)
Inventor
Steven J Cohen
Tamar Jehuda-Cohen
Original Assignee
Shiloov Medical Technologies L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shiloov Medical Technologies L filed Critical Shiloov Medical Technologies L
Application granted granted Critical
Publication of ATE191791T1 publication Critical patent/ATE191791T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G01N33/56988—HIV or HTLV
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Virology (AREA)
  • Food Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • AIDS & HIV (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Prostheses (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT93900599T 1991-11-25 1992-11-24 Verfahren für die bestimmung von antikörpern in seronegativen personen ATE191791T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US79773091A 1991-11-25 1991-11-25
PCT/US1992/010075 WO1993011435A1 (en) 1991-11-25 1992-11-24 Method and kit for the detection of antibodies in seronegative individuals

Publications (1)

Publication Number Publication Date
ATE191791T1 true ATE191791T1 (de) 2000-04-15

Family

ID=25171653

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93900599T ATE191791T1 (de) 1991-11-25 1992-11-24 Verfahren für die bestimmung von antikörpern in seronegativen personen

Country Status (13)

Country Link
US (2) US5637453A (de)
EP (1) EP0643838B1 (de)
JP (2) JPH07509557A (de)
AT (1) ATE191791T1 (de)
CA (2) CA2200363A1 (de)
DE (1) DE69230918T2 (de)
DK (1) DK0643838T3 (de)
ES (1) ES2147195T3 (de)
GR (1) GR3033919T3 (de)
IL (2) IL103852A (de)
PT (1) PT643838E (de)
WO (1) WO1993011435A1 (de)
ZA (1) ZA929160B (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6280962B1 (en) 1991-11-25 2001-08-28 Yoreh Biotechnologies Ltd. Whole blood/mitogen assay for the early detection of a subject with cancer and kit
US6352826B1 (en) 1991-11-25 2002-03-05 Yoreh Biotechnologies, Ltd. Method and kit for the detection of retroviral specific antibodies in seronegative individuals
US6322989B1 (en) 1991-11-25 2001-11-27 Yoreh Biotechnologies, Ltd. Whole blood/mitogen assay for the early detection of a subject with ovarian or breast cancer and kit
JP2001504233A (ja) * 1996-11-22 2001-03-27 シルーヴ メディカル テクノロジーズ リミテッド 癌を有する被験者の早期検出のための全血／マイトジェンアッセイおよびキット
EP0973944A1 (de) * 1997-03-31 2000-01-26 Abbott Laboratories Reagentien und verfahren zur erkennung von krankheiten des gastrointestinaltraktes
WO1998044160A1 (en) * 1997-03-31 1998-10-08 Abbott Laboratories Reagents and methods useful for detecting diseases of the gastrointestinal tract
GB9913819D0 (en) 1999-06-14 1999-08-11 Plasmacute As Assay
DE10125730A1 (de) * 2001-05-17 2002-11-21 A I D Autoimmun Diagnostika Gm Verfahren zum Nachweis von Erregern und durch diese induzierten zellulär produzierten Stoffen im lebenden Organismus
WO2004064608A2 (en) * 2003-01-17 2004-08-05 Aethlon Medical, Inc. Method for removal of viruses from blood by lectin affinity hemodialysis
GB0325483D0 (en) * 2003-10-31 2003-12-03 Plasmacute As Assay
EP2309269B1 (de) * 2004-09-08 2016-10-26 THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES Zusammensetzungen und verfahren zur detektion von hiv-1/hiv-2 infektion
US7770050B2 (en) * 2006-05-03 2010-08-03 Sony Computer Entertainment Inc. Method and apparatus for resolving clock management issues in emulation involving both interpreted and translated code
CA2810770A1 (en) * 2010-09-07 2012-03-15 Smart Biotech Ltd. Methods and kits for the detection of an infection in subjects with low specific antibody levels
BR112013024317A2 (pt) * 2011-03-23 2019-09-24 Smart Biotech Ltd método e kit para a determinação do tempo de seroconversão de um paciente infectado com um vírus
US9651557B2 (en) * 2012-03-08 2017-05-16 Dror Atzmon Method and kit for the detection of hepatitis-specific antibodies
WO2013132496A1 (en) * 2012-03-08 2013-09-12 Smart Biotech Ltd. Methods and kits for the detection of viral infections
WO2016014861A1 (en) * 2014-07-25 2016-01-28 Incelldx, Inc. Methods of evaluating a cellular sample for latent cellular replication competent hiv-1, and compositions and kits for use in practicing the same
DE102019214137A1 (de) * 2019-09-17 2021-03-18 Hot Screen Gmbh Verwendung in vitro eines Kits und eines Verfahrens zur Diagnostik von Transplantationen und/oder Autoimmunerkrankungen und/oder Tumorerkrankungen und/oder Vakzinierungen sowie ein botenstoffhaltiger Überstand, zellhaltiges Sediment und eine Kombination zur Anwendung bei der Diagnostik von Transplantationen und/oder Autoimmunerkrankungen und/oder Tumorerkrankungen und/oder Vakzinierungen
CN113917162B (zh) * 2021-12-14 2022-04-01 江苏为真生物医药技术股份有限公司 去唾液酸糖蛋白受体片段sH2a作为标志物的应用

Also Published As

Publication number Publication date
JPH07509557A (ja) 1995-10-19
EP0643838A4 (de) 1996-02-28
WO1993011435A1 (en) 1993-06-10
EP0643838B1 (de) 2000-04-12
DE69230918D1 (de) 2000-05-18
US5637453A (en) 1997-06-10
CA2200363A1 (en) 1993-05-26
JPH11237381A (ja) 1999-08-31
EP0643838A1 (de) 1995-03-22
US20020006608A1 (en) 2002-01-17
IL125330A0 (en) 1999-08-17
CA2124319A1 (en) 1993-06-10
IL103852A0 (en) 1993-04-04
ES2147195T3 (es) 2000-09-01
GR3033919T3 (en) 2000-11-30
DK0643838T3 (da) 2000-09-11
DE69230918T2 (de) 2000-11-09
ZA929160B (en) 1993-08-16
PT643838E (pt) 2000-10-31
IL103852A (en) 1999-06-20

Similar Documents

Publication Publication Date Title
ATE191791T1 (de) Verfahren für die bestimmung von antikörpern in seronegativen personen
ATE179716T1 (de) Verfahren zur bestimmung von peptiden, die immunologisch wichtigen epitopen von hcv zugehörig sind
NO169844C (no) Htlv-iii (env)-peptider
EA200100943A1 (ru) Вич-пептиды, антигены, вакцинные композиции, набор для иммуноанализа и способ определения вич-индуцированных антител
ATE172542T1 (de) Vergrössertes western blot format und ein immunotestverfahren für die bestimmung von viralen antikörpern
DE69013950D1 (de) Monoklonaler Antikörper zur Unterscheidung HIV-2-seropositiver von HIV-1-seropositiven Individuen.
ATE67313T1 (de) Nachweis von menschlichem cytomegalovirusspezifischem igm.
DE69131707D1 (de) Nachweis von Hepatits C mit Verwendung rekombinanter Antigene
DE3854553D1 (de) Verfahren zum schnellen und empfindlichen Nachweis von IgM-Antikörpern gegen retrovirale Antigene.
DE3584872D1 (de) Verfahren zur herstellung von monoklonalen antikoerpern gegen hbsag.
Kataaha et al. Stimulation of autoantibody production in normal blood lymphocytes by malaria culture supernatants
ATE128716T1 (de) Hiv-peptide und methoden für den nachweis von hiv.
SE9000595D0 (sv) New peptides, diagnostic antigens and an immunoassay method
DE69026875D1 (de) Immunobestimmung von menschlichem osteocalcin, reagenz und satz dafür
ATE108457T1 (de) Synthetische antigene zur bestimmung der aids- bezogenen, von lav-2 verursachten krankheiten.
CA2095735A1 (en) Monoclonal antibodies to hepatitis c virus and method for using same
ATE4282T1 (de) Verfahren zur herstellung von toxoplasmenbereitungen fuer die toxoplasmosediagnose und die so hergestellten bereitungen.
ATE352785T1 (de) Verfahren zum nachweis von hepatitis c antigenen
EP0402757A3 (de) Festphasenimmunoassay und Testbesteck zur Bestimmung von Antigenen und Antikörpern
ATE367582T1 (de) Verfahren zum nachweis von borna-disease-virus (bdv)- infektionen
Laperche et al. Comparative evaluation of the Geenius HCV supplemental assay and Inno-LIA HCV score assay in detecting anti-HCV antibodies
ATE134649T1 (de) Arzneimittel und verfahren zur behandlung von erworbenem immundefizienzsyndrom (aids) und aids- verwandtem komplex unter verwendung von karbohydratspezifischen antikörpern
Garnham et al. Application of the soluble antigen fluorescent antibody (SAFA) test to the serodiagnosis of rabies
UA23988A (uk) Спосіб діагhостики сhіду
ATE142342T1 (de) Benutzung von sp-2 monoklonalen antikörpern zur diagnostik und zur beobachtung des hiv- infektionsfortschritts